Action 301108 TONGLING JIEYA BIOLOGIC TECHNOLOGY CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Tongling Jieya Biologic Technology Co., Ltd.

Actions

301108

CNE1000054S9

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 17/05/2024 		Varia. 5j. Varia. 1 janv.
27,67 CNY +0,11 % Graphique intraday de Tongling Jieya Biologic Technology Co., Ltd. -8,29 % -19,89 %
25/04 Tongling Jieya Biologic Technology Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
15/04 Tongling Jieya Biologic Technology Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tongling Jieya Biologic Technology Co., Ltd. commences an Equity Buyback Plan for CNY 40 million worth of its shares, under the authorization approved on March 13, 2024.
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2023.
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Tongling Jieya Biologic Technology Co., Ltd. agreed to acquire 20% stake in Sateri Nonwoven Materials Co., Ltd. from Sateri Fiber Co., Ltd. for CNY 16.5 million.
Tongling Jieya Biologic Technology Co., Ltd. Approves Cash Dividend on A shares for 2022, Payable on 26 May 2023
Tongling Jieya Biologic Technology Co., Ltd. Proposes Final Cash Dividend for 2022
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2022.
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Tongling Jieya Biologic to Free Up More than 1 Milion Shares For Trading
Tongling Jieya Biologic Technology Co., Ltd. Approves Final Cash Dividend for the Year 2021
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Tongling Jieya Biologic Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Tongling Jieya Biologic Technology Co., Ltd. has completed an IPO in the amount of CNY 1.162722 billion.
Tongling Jieya Biologic Technology Co., Ltd. has filed an IPO.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 301108
  4. Actualités Tongling Jieya Biologic Technology Co., Ltd.
  5. Autres langues